COVID-19 Infection Does Not Impact Symptom Severity or Disability Trajectory in Multiple Sclerosis
Community Efforts to Standardize and Improve ALS Diagnosis: Kuldip Dave, PhD
Episode 132: Aiding Diagnosis of Synucleinopathies Through SAAmplify-aSYN Biomarker Test
FDA Grants Breakthrough Therapy Designation to Denali’s Tividenofusp Alfa for Hunter Syndrome